HemoGenyx

HemoGenyx

HemoGenyx

HemoGenyx, a privately held biopharmaceutical company, is developing new sources of hemogenic cells for hematopoietic system regeneration.
Raised
$1.3M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$1,000,000
Seed fund - 2016
$250,000
Seed fund - 2014
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when HemoGenyx makes some noise.